Wuzhou Red Cross Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
32 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Bin
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

Active, not recruiting
4
2500
RoW
Sodium Oligomannate Capsules
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer Disease
01/25
04/25
NCT06477237: Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting
3
400
RoW
HB0017 Q4W, HB0017 Q8W, placebo
Huabo Biopharm Co., Ltd.
Psoriasis
08/24
12/25
NCT06631170: Efficacy and Safety of Roflumilast Cream in Subjects with Atopic Dermatitis

Recruiting
3
351
RoW
Roflumilast Cream 0.15%, Vehicle cream
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Atopic Dermatitis (AD)
08/25
08/25
NCT05527470: Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Recruiting
3
440
RoW
Gemcitabine,Cisplatin, Induction chemotherapy regimen, Intensity-modulated radiation therapy (IMRT), Cisplatin, Concurrent chemotherapy regimen
Wei Jiang, Wuzhou Red Cross Hospital, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Lingshan people's Hospital, Laibin People's Hospital, Nationalities Hospital of Guangxi Zhuang Autonomous Region
Nasopharyngeal Carcinoma
11/25
11/27
NCT06010693: A Study of Daridorexant in Chinese Patients With Insomnia Disorder

Completed
3
206
RoW
Daridorexant, Placebo
Jiangsu Simcere Pharmaceutical Co., Ltd.
Insomnia Disorder
04/24
05/24
NCT05431413: Rapid Improvement of Depression of Fluoxetine Combined With ATP

Recruiting
2
195
RoW
Control group: Fluoxetine and Placebo, Experimental group: Fluoxetine and ATP, Control group: Fluoxetine and Phosphocreatine
Nanfang Hospital, Southern Medical University
Depression
12/25
12/25
ACAC, NCT06607276: Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE

Recruiting
2
122
RoW
Adebrelimab and capecitabine, capecitabine
The First Affiliated Hospital with Nanjing Medical University, Jinling Hospital, China
Cholangiocarcinoma Cancer, Adebrelimab (SHR-1316)
09/26
09/27
GLMU-07, NCT05097209: Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Recruiting
2
200
RoW
Camrelizumab, PD-1 antibody, Gemcitabine, Gem, Induction Cisplatin, DDP, intensity-modulated radiotherapy, IMRT, Concurrent cisplatin
Wei Jiang, Wuzhou Red Cross Hospital, Guangxi Nanxishan Hospital, Laibin People's Hospital, Lingshan people's Hospital
Nasopharyngeal Carcinoma
04/25
04/26
NCT05764798: Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms

Recruiting
1
60
RoW
Experimental group: Shugan Jieyu Capsule combined with zolpidem, Control group: Placebo combined with zolpidem
Nanfang Hospital of Southern Medical University
Insomnia
12/24
12/24
NCT05056116: A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

Recruiting
N/A
30
RoW
Surufatinib Toripalimab, Surufatinib/JS001
The Affiliated Hospital of Xuzhou Medical University
Biliary Tract Cancer
06/22
06/24
NCT04853485: Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

Recruiting
N/A
300
RoW
repetitive transcranial magnetic stimulation (rTMS)
Shanghai Jiao Tong University School of Medicine, Suzhou Psychiatric Hospital, Guangzhou Psychiatric Hospital, Shenzhen Kangning Hospital, Tianjin Anding Hospital, Nantong Fourth People's Hospital & Nantong Brain Hospital
Schizophrenia; Psychosis, First Episode Psychosis, Clinical High Risk
12/23
12/24
PROEM, NCT06225947: Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia

Recruiting
N/A
200
RoW
Lemborexant 5 MG, DAYVIGO
Guangdong Provincial People's Hospital, Nanfang Hospital, Southern Medical University
Insomnia
03/25
06/25
NCT06492746: Personal BP - CAI Study

Recruiting
N/A
120
US
HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring
Edwards Lifesciences
Blood Pressure
05/25
05/25
COAST, NCT03653156: China Cognition and Aging Study

Recruiting
N/A
100000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia
01/38
01/38
CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting
N/A
40000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Alzheimer Disease, Familial Alzheimer Disease (FAD)
01/38
01/38
NCT04979325: Cross-sectional Survey of Zhejiang ECMO Application

Not yet recruiting
N/A
1
RoW
Second Affiliated Hospital, School of Medicine, Zhejiang University, Sir Run Run Shaw Hospital, Zhejiang Provincial People's Hospital, Zhejiang Hospital, The First Affiliated Hospital of Zhejiang Chinese Medical University, First People's Hospital of Hangzhou, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Third People's Hospital, Red Cross Hospital, Hangzhou, China, Hangzhou Children's Hospital, The First Hospital of Fuyang District, Hangzhou, The First Hospital of Xiaoshan District, Hangzhou, The First Hospital of Linping District, Hangzhou, The First Hospital of Lin'an District, Hangzhou, The First Hospital of Tonglu County, Hangzhou, The First Hospital of Jiande County, Hangzhou, The First Hospital of Chun'an County, Hangzhou, Affiliated Cixi Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Ningbo First People's Hospital
Extracorporeal Membrane Oxygenation, Cardiopulmonary Resuscitation, Epidemiology
08/21
09/21
CHEN, XUAN
TREND-IVT, NCT06548971: Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke

Recruiting
3
1184
RoW
Aspirin, Placebo, Best medical management
Capital Medical University
Acute Ischemic Stroke, Cerebral Infarction
03/26
03/26
NCT06479343: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Recruiting
N/A
170
RoW
Liquid Embolic System (Tonbridge), Onyx Liquid Embolic System (Medtronic)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Intracranial Arteriovenous Malformations
10/25
10/26
Liang, Jin-Hui
2021-FXY-452, NCT05211232: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Active, not recruiting
3
450
RoW
Tislelizumab, BGB-A317, Placebo
Sun Yat-sen University, Cancer Hospital of Guizhou Province, Hunan Cancer Hospital, Wuzhou Red Cross Hospital, Affiliated Hospital of Guangdong Medical University
Nasopharyngeal Carcinoma
05/26
05/28
NCT04453813: Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Recruiting
3
226
RoW
Toripalimab plus concurrent chemo-radiotherapy, Concurrent chemo-radiotherapy
Sun Yat-sen University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Zhongshan People's Hospital, Guangdong, China, Yuebei People's Hospital, Wuzhou Red Cross Hospital, Fifth Affiliated Hospital, Sun Yat-Sen University
Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
07/25
07/27
NCT04448522: Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Recruiting
3
508
RoW
reduced dosage IMRT, conventional dosage IMRT
Sun Yat-sen University, National Cancer Centre, Singapore, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Zhongshan People's Hospital, Guangdong, China, Yuebei People's Hospital, Wuzhou Red Cross Hospital
Nasopharyngeal Carcinoma, Radiotherapy, Chemotherapy
08/26
08/28
NCT04453826: Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Recruiting
3
388
RoW
Camrelizumab plus chemo-radiotherapy, Chemo-radiotherapy alone
Sun Yat-sen University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Zhongshan People's Hospital, Guangdong, China, Yuebei People's Hospital, Wuzhou Red Cross Hospital, Fifth Affiliated Hospital, Sun Yat-Sen University
Nasopharyngeal Cancer, Chemotherapy, Radiotherapy, PD-1 Therapy
09/26
09/28
Fu, Min-Yi
NCT04778956: Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Recruiting
3
218
RoW
Toripalimab, PD-1 antibody, salvage surgery
Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Zhongshan People's Hospital, Guangdong, China, Tenth Affiliated Hospital, Sun Yat-sen University
Nasopharyngeal Carcinoma, PD-1, Surgery
03/25
03/33
YKP2023-02-04, NCT06445088: Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

Recruiting
N/A
908
RoW
VCA-IgA, EBNA1-IgA, and EBV-DNA, EBV C Promoter Methylation Detection in nasopharyngeal swab samples
Sun Yat-sen University, Fujian Cancer Hospital, Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China, First Affiliated Hospital of Guangxi Medical University
Nasopharyngeal Carcinoma
12/26
12/26
Sun, Chenghe
TREND-IVT, NCT06548971: Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke

Recruiting
3
1184
RoW
Aspirin, Placebo, Best medical management
Capital Medical University
Acute Ischemic Stroke, Cerebral Infarction
03/26
03/26
Cai, Yonglin
NCT04085900: Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City

Recruiting
N/A
40000
RoW
Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic endoscopy and biopsy
Zhongshan People's Hospital, Guangdong, China, Wuzhou Red Cross Hospital, Xiamen University
Nasopharyngeal Carcinoma
12/24
12/27
Gao, Jianquan
NCT05717790: Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Recruiting
N/A
288
RoW
Nimotuzumab, h-R3, BIOMAb EGFR, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT
Fourth Affiliated Hospital of Guangxi Medical University, People's Hospital of Baise, Second Affiliated Hospital of Guangzhou Medical University, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin Medical University, China, LiuZhou People's Hospital, The First People's Hospital of Qinzhou, Wuzhou Red Cross Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
Nasopharyngeal Carcinoma by AJCC V8 Stage
11/24
11/27
Ji, Ming-Fang
EBVCR, NCT06203314: Epstein-Barr Virus and Cancer Risks

Recruiting
N/A
100000
RoW
Diagnostic test: EBV antibody tests
Sun Yat-sen University, Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China
Cancer
12/24
12/30
Tang, Min-Zhong
EBVCR, NCT06203314: Epstein-Barr Virus and Cancer Risks

Recruiting
N/A
100000
RoW
Diagnostic test: EBV antibody tests
Sun Yat-sen University, Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China
Cancer
12/24
12/30
YKP2023-02-04, NCT06445088: Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

Recruiting
N/A
908
RoW
VCA-IgA, EBNA1-IgA, and EBV-DNA, EBV C Promoter Methylation Detection in nasopharyngeal swab samples
Sun Yat-sen University, Fujian Cancer Hospital, Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China, First Affiliated Hospital of Guangxi Medical University
Nasopharyngeal Carcinoma
12/26
12/26
Xu, Zhuohua
NCT05892354: Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Recruiting
N/A
190
RoW
Enteral immunonutrition, Standard enteral nutrition
First Affiliated Hospital of Guangxi Medical University, Guangdong Provincial People's Hospital, Zhejiang Cancer Hospital, Zhejiang Provincial People's Hospital, Fujian Cancer Hospital, Fujian Provincial Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Qingdao Central Hospital, Huizhou Municipal Central Hospital, Haikou People's Hospital, The Second Affiliated Hospital of Hainan Medical University, Zhejiang Provincial Tongde Hospital, Guilin Medical University, China, Liuzhou Workers Hospital, Wuzhou Red Cross Hospital, Red Cross Hospital of Yulin City, First People's Hospital of Yulin, Hainan Cancer Hospital
Locally Advanced Nasopharyngeal Carcinoma
04/25
04/27
Xun, Chen
NCT06315231: Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

Recruiting
2
200
RoW
Edaravone dexborneol sublingual tablet, Placebo
Simcere Pharmaceutical Co., Ltd
Post-stroke Cognitive Impairment
12/26
12/26

Download Options